Lack of Clinical Evidence Critical gaps in knowledge: Zero randomized controlled trials on microdosing GLP-1 agonists No long-term safety data for alternative dosing regimens Unknown effects on cardiovascular outcomes Potential for reduced efficacy not captured in models 3
The Onyx Biolabs IGF-1 LR3 Peptide 1mg (Insulin-like Growth Factor-1 Long Arg3) is a highly purified, synthetic protein and lengthened analogue of human IGF-1
Ozempic is approved to reduce the risks of major cardiovascular events and complications from kidney disease, a benefit not shared by Mounjaro
In this latter pathway the nitrogen is removed from adenosine generating inosine by the critical enzyme, adenosine deaminase, ADA
In the pivotal STEP 1 trial the largest dedicated Wegovy weight loss study participants lost an average of 15% of body weight over 68 weeks
The most frequently investigated GLP-1 RAs were liraglutide and semaglutide, predominantly administered via the subcutaneous route